Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 107 | Vintage Vibes

Health department says fifth COVID-19 vaccine doses not being recommended for most people amid rising cases

The Department of Health says fifth doses of a COVID-19 vaccine are not currently being recommended for most people.

ABC News

Dutch, UK fentanyl sellers hit with Treasury sanctions

Two Dutch nationals, an Englishman and nine companies have been targeted for sanctions by the U.S. government for allegedly operating an illegal fentanyl ring that generated millions of dollars in virtual currency

The Independent UK

Parents urged to support research aimed at protecting babies from RSV infections

Respiratory Syncytial Virus is the leading cause of infant hospital admissions in the UK.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

StockNews.com

EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring

Benzinga

Inhalable and nasal Covid vaccines could trump regular shots

We need to consider a vaccine strategy that will provide longer-term immunity

Wales Online

Pfizer’s COVID cash powers a ‘marketing machine’ on the hunt for new supernovas

For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Needle-free COVID-19 vaccine trial begins on the Sunshine Coast in Australian-first

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

ABC News

Pfizer boss labels Covid a 'multibillion-dollar franchise' as vaccine cost set to soar

Chief financial officer David Denton reportedly told investors at the drug maker that he expects profits will continue to rise

Wales Online

Breakthrough Covid drug for vulnerable proven to save lives - but it's not free on NHS

Research suggests the drug, called Evusheld, would be 88% effective at preventing intensive care admission for people with weakened immune systems still shielding from Covid because vaccines don't work for them.

Daily Mirror

Widening tech, biotech job cuts could jolt broader Bay Area economy: experts

SAN JOSE, Calif. — Bay Area tech and biotech companies have recently revealed plans to chop thousands of jobs, layoffs that raise the specter that these cutbacks might haunt the region’s broader economy.

Tribune News Service

Novavax says Omicron shot shows strong immune response as second booster

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.

Reuters

Psychedelic drug research held back by UK rules and attitudes, say scientists

Active ingredient of magic mushrooms still classified as having no medical value, despite clinical success

The Guardian - UK

Omicron 'grandchildren' mean 300 Covid-19 strains now discovered across the world

The World Health Organisation (WHO) has said these are filling the gaps where Omicron was once rampant

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Pandemic greed killed 1.3 million: study

Hoarding vaccines led to 1.3 million unnecessary deaths, while rich countries wasted their shots

Reuters

Uganda shortens school term by two weeks to curb Ebola

Uganda will shorten the school term by two weeks to reduce daily contact amongst students and help curb the spread of Ebola, the education minister said on Tuesday.

ABC News

Calls to expand fifth COVID vaccine rollout as ATAGI considers guidelines

Pressure is mounting on the federal government to expand access to fifth COVID vaccine doses, with a growing number of vulnerable Australians facing waning immunity at a time when case numbers across the country are expected to rise.

Wales Online

Needle-free Covid vaccines could be the key to beating the virus

Mucosal vaccines are delivered in your nose or throat, as sniffable or inhalable formulation

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Pill to prevent pre-eclampsia gets UK fast track for development

Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition

Evening Standard

‘Exciting’ new drug found to reduce blood pressure in patients resistant to treatment

Trial finds drug Baxdrostat to be successful in bringing down blood pressure

Wales Online

New drug could help tackle 'untreatable' high blood pressure

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

The Independent UK

‘Exciting’ development in tackling untreatable high blood pressure

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

Evening Standard

Study shows ‘significant drop’ in confidence in vaccines since start of Covid

Scientists warn Covid jab met with ‘particular hostility’ despite evidence of safety

The Independent UK

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier

StockNews.com

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

1 … 106 107 108 109

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.